U.S. CDC wanting into coronary heart irritation in some younger vaccine recipients By Reuters


© Reuters. FILE PHOTO: People wait after receiving a vaccine against coronavirus disease (COVID-19) at a Philadelphia Department of Public Health clinic working with the Black Doctors COVID-19 consortium to encourage vaccination to all eligible teenagers

By Radhika Anilkumar

(Reuters) – Some teenagers and young adults who received COVID-19 vaccines had inflammation of the heart, an advisory group from the U.S. Centers for Disease Control and Prevention said, recommending further investigation for the rare disease.

The CDC’s Advisory Committee on Immunization Practices, in a May 17 statement, said it had examined reports that some young vaccine recipients, mostly adolescents and young adults, and mostly men, developed myocarditis, an inflammation of the heart muscle.

The disease often goes away without complications and can be caused by a variety of viruses, the CDC group said.

CDC surveillance systems had found no more cases than expected in the population, but members of the vaccination committee felt that health care providers should be made aware of the reports of the “potential adverse event,” the committee said in the statement.

The number of people affected was not reported and further investigation was recommended.

Dr. Amesh Adalja, senior scientist at the Johns Hopkins Center for Health Security, said vaccines are known to cause myocarditis and are important to monitor if they are causally related to the vaccine. It is important to look at the risk-benefit ratio, he added. “Vaccines will clearly be much more beneficial because they outweigh this very small, if definitive, risk.”

The CDC said the cases typically appeared within four days of receiving the mRNA vaccines. It was not specified which vaccines. The United States has given emergency approval to two mRNA vaccines Modern (NASDAQ 🙂 Inc and Pfizer / BioNTech.

The Israeli Ministry of Health said in April it is investigating a small number of cases of heart infections in people who have received it Pfizer (NYSE 🙂 ‘s vaccine, although it had not yet drawn any conclusions. Most of the cases in Israel have been reported in people up to the age of 30.

Pfizer said at the time that it had not observed a higher rate of the disease than would normally be seen in the general population and that no causal link had been established with the vaccine.

Pfizer and Moderna did not immediately respond to requests for comment on Saturday.

After news of the Israeli investigation in late April, the CDC said it saw no connection between the two.

Earlier this month, U.S. regulators expanded the approval of Pfizer and BioNTech’s COVID-19 vaccine for children ages 12-15.

The New York Times previously covered the CDC statement.

Disclaimer: Fusion Media would like to remind you that the information contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges, but by market makers. Therefore, prices may not be accurate and may differ from the actual market price. This means that the prices are indicative and not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading losses you may incur as a result of using this data.

Fusion Media or any person involved with Fusion Media assumes no liability for any loss or damage caused by reliance on the information contained on this website, such as data, offers, charts and buy / sell signals. Please inform yourself comprehensively about the risks and costs associated with trading in the financial markets. This is one of the riskiest forms of investment possible.

Leave A Reply

Your email address will not be published.